Silverarc Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Silverarc Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-31,040	Closed	-$626K	–	95
2021 Q3	$626K	Sell	31,040 -198,852	-86%	-$5.49M	0.35%	63
2021 Q2	$8.58M	Buy	229,892 +29,892	+15%	+$916K	3.83%	3
2021 Q1	$5.11M	Sell	200,000 -27,388	-12%	-$700K	2.79%	8
2020 Q4	$5.01M	Buy	+227,388	New	+$5.01M	2.91%	7

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return

Silverarc Capital Management's DRNA Position: Q4 2021 in Review

Silverarc Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 31,040 shares — an estimated $626K sold.

Silverarc Capital Management first reported a position in DRNA in Q4 2020 and held it in 4 quarters. The position peaked at $8.58M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Silverarc Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Silverarc Capital Management sold 31,040 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $626K.
Silverarc Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2020 and held it in 4 quarters.
Silverarc Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $8.58M in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Silverarc Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.